Grant: CanExport Innovation
Syng Pharmaceuticals Inc.
$4,575.00
Syng Pharmaceuticals Inc.-2025-2026-1036923
FY 2025-26 · 2025-09-07
Summary
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Department
Program
CanExport Innovation
Recipient
Location
Kingston|Kingston, Ontario, Canada
Recipient Type
For-profit organization
Business Number
842703845
Type
Grant
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2026-03-31
Agreement Number
1036923
Agreement Start Date
2025-09-07
Agreement Title
Syng Pharmaceuticals Inc.-2025-2026-1036923
Agreement Title (French)
Syng Pharmaceuticals Inc.-2025-2026-1036923
Agreement Type
Grant
Agreement Value
$4,575.00
Amendment Number
0
Description
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Description (French)
Le présent accord du programme CanExport Innovation a pour objet de soutenir les organisations canadiennes à mener des activités l’établissement de partenariats entre le récipiendaire et des organisations étrangères afin de mener de la R et D sur la technologie du récipiendaire et qui pourraient mener à sa commercialisation.
Expected Results
Increase Canadian science and technological innovation and commercialization opportunities as measured by analysis of recipient performance reports and surveys.
Expected Results (French)
Accroître les possibilités d’innovation et de commercialisation de la science et de la technologie canadiennes; ce résultat est évalué par l’analyse des rapports et des sondages sur le rendement des bénéficiaires.
Federal Riding
Kingston and the Islands
Federal Riding (French)
Kingston et les Îles
Federal Riding Number
35044
NAICS Code
54171
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
CanExport Innovation
Program Name (French)
CanExport Innovation
Program Purpose
The Program is designed to promote and enhance Canada’s international innovation efforts by providing direct financial assistance to the Recipient (Canadian small and medium-size enterprises, academic institutions and non-government research centres) to pursue international opportunities that could lead to the establishment of new collaborative Research and Development (R&D) partnerships with key players in foreign markets.
Program Purpose (French)
Le Programme est conçu pour promouvoir et améliorer les efforts d’innovation internationaux du Canada en fournissant une aide financière directe au récipiendaire (petites et moyennes entreprises canadiennes, établissements d’enseignement canadiens et centres de recherche non gouvernementaux canadiens) afin de saisir des occasions susceptibles de mener à l’établissement de partenariats en recherche et développement (R et D) avec des partenaires clés dans des marchés étrangers.
Recipient Business Number
842703845
Recipient City
Kingston|Kingston
Recipient Country
CA
Recipient Legal Name
Syng Pharmaceuticals Inc.
Recipient Operating Name
SYNG Pharmaceuticals
Recipient Postal Code
K7P0L5
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2025-2026-Q3-1036923